Dr Terry Aspray is a Consultant in Metabolic Bone Disease at Newcastle’s Freeman Hospital.
An accredited physician, Dr Asptry trained in osteoporosis and metabolic medicine in Cambridge and the North East.
He leads Newcastle’s Bone Clinic which treats patients with metabolic bone disease, including DXA scanning and a fracture liaison service for Newcastle, with two Lunar iDXA scanners on site (and 2 more iDXA scanners based in the clinical research facility).
The team offers a specialised regional clinical service for patients with rarer conditions, including fibrous dysplasia, osteogenesis imperfecta and hypophosphatasia. A specialised transition clinical service includes liaison with genetics services, the muscle clinic at the Centre for Life as well as a monthly genetics clinic, attended by a colleague from the clinical genetics service.
Newcastle’s Metabolic Bone Unit participates in commercial and non-commercial clinical studies and clinical trials, currently on rare metabolic diseases (RUDY), osteogenesis imperfecta (Asteroid and TOPAZ) as well as recruiting participants to the NIHR BioResource:NIHR BioResource website
Current research includes a portfolio of projects on vitamin D, with a recently published clinical trial (VDOP: https://academic.oup.com/ajcn/article/109/1/207/5280801) and 4 PhD students looking at aspects of vitamin D and: muscle, sun exposure, renal function and ageing.
We anticipate further research developments on nutrition, muscle, vitamin D and Paget’s Disease of bone with important collaborations locally with colleagues at:Newcastle University (HNRC) Newcastle NIHR Biomedical Research Centre website
and the Universities of East Anglia and Edinburgh.Back to Rheumatology Services